|
|
FI Knoll Capital Management
|
|
|
|
Office Locations:
|
5 East 44th Street 12th floor
New York, NY 10017
Phone: 212-808-7474
| | |
|
|
|
|
|
Information Technology
Life Sciences & Healthcare
|
|
|
|
Knoll Capital Management is an investment management firm founded by Fred Knoll. Knoll runs the trust for the benefit of his family and it was the fifth-biggest owner of cancer drug maker Medivation's shares at the end of 2015. His 2.67% stake in Medivation made up 79% of Knoll's $270 million U.S. stock portfolio at the end of 2015, Securities & Exchange Commission filings show. Knoll's stake in Medivation alone is now worth $270 million. Knoll has led Knoll Capital Management since 1987, and he personally manages Knoll Capital Fund I and Knoll Capital Fund II. The firm's current investments mostly consist of biotech companies.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
